Login
欢迎浏览恩派尔生物资料网
我要投稿 请登录 免费注册 安全退出

  • Genetic Analysis of Drug Resistance by Fluorescence In Situ Hybridization

    Genetic Analysis of Drug Resistance by Fluorescence In Situ Hybridization

    Tumor progression is driven by the accumulation of genetic changes, which, in ag

    2025-03-15 41
  • Detection of Apoptosis by the TUNEL Assay

    Detection of Apoptosis by the TUNEL Assay

    Apoptosis is the name given to a normal cell process—that of programmed cell dea

    2025-03-15 32
  • Backtracking of Leukemic Clones to Birth

    Backtracking of Leukemic Clones to Birth

    Many of the acquired genetic changes that contribute to the molecular pathogenes

    2025-03-15 36
  • Integrating Molecular Biomarkers into Current Clinical Management in Melanoma

    Integrating Molecular Biomarkers into Current Clinical Management in Melanoma

    Personalized melanoma medicine has progressed from histopathologic features to s

    2025-03-15 45
  • Proteomics and Cancer Epidemiology

    Proteomics and Cancer Epidemiology

    Profiling of differentially expressed proteins is perhaps the most important and

    2025-03-15 37
  • Ovarian Cancer Stem Cells Enrichment

    Ovarian Cancer Stem Cells Enrichment

    The concept of cancer stem cells (CSCs) provides a new paradigm for understandin

    2025-03-15 38
  • Epidemiological Investigation of Prostate Cancer

    Epidemiological Investigation of Prostate Cancer

    Prostate cancer is the most common male cancer diagnosed in Western populations.

    2025-03-15 40
  • Immunohistochemical Evaluation of Biomarkers in Prostatic and Colorectal Neoplasia: Principles and G

    Immunohistochemical Evaluation of Biomarkers in Prostatic and Colorectal Neoplasia: Principles and G

    In Chapter 10 of thts volume and in prior publications (1 ,2 ), the matertals an

    2025-03-15 30
  • Procedures for the Quantitative Protein Determination of Urokinase and Its Inhibitor, PAI-1, in Huma

    Procedures for the Quantitative Protein Determination of Urokinase and Its Inhibitor, PAI-1, in Huma

    The determination of the protein content of urokinase-type plasminogen activator

    2025-03-15 36
  • Detection of the Transcripts and Proteins for the Transforming Growth Factor- Isoforms and Receptors

    Detection of the Transcripts and Proteins for the Transforming Growth Factor- Isoforms and Receptors

    Several critical polypeptide growth factors have been identified for the lung, i

    2025-03-15 29
  • Use of Proteomics to Study Chemosensitivity

    Use of Proteomics to Study Chemosensitivity

    Chemoresistance remains an unresolved problem in clinical oncology. Therefore it

    2025-03-15 39
  • Analyzing Cell Cycle Checkpoints After Ionizing Radiation

    Analyzing Cell Cycle Checkpoints After Ionizing Radiation

    Several methods to measure cell cycle perturbation after exposure to ionizing ra

    2025-03-15 43
  • Manipulating Genes and Gene Copy Number by Bacterial Artificial Chromosome Transfection

    Manipulating Genes and Gene Copy Number by Bacterial Artificial Chromosome Transfection

    Bacterial artificial chromosomes (BACs) provide a well-characterized resource fo

    2025-03-15 40
  • DNA Methylation and Histone Modifications in Breast Cancer

    DNA Methylation and Histone Modifications in Breast Cancer

    Breast cancer is caused by progressive genetic alterations and epigenetic change

    2025-03-15 39
  • Diagnosis and Monitoring of CBFB-MYH11-Positive Acute Myeloid Leukemia by Qualitative and Quantitati

    Diagnosis and Monitoring of CBFB-MYH11-Positive Acute Myeloid Leukemia by Qualitative and Quantitati

    During the last decade, many mutations present in myeloid leukemias have been mo

    2025-03-15 48